Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells

BackgroundThe cyclin E oncogene activates CDK2 to drive cells from G1 to S phase of the cell cycle to commence DNA replication. It coordinates essential cellular functions with the cell cycle including histone biogenesis, splicing, centrosome duplication and origin firing for DNA replication. The two E-cyclins, E1 and E2, are assumed to act interchangeably in these functions. However recent reports have identified unique functions for cyclins E1 and E2 in different tissues, and particularly in breast cancer.FindingsCyclins E1 and E2 localise to distinct foci in breast cancer cells as well as co-localising within the cell. Both E-cyclins are found in complex with CDK2, at centrosomes and with the splicing machinery in nuclear speckles. However cyclin E2 uniquely co-localises with NPAT, the main activator of cell-cycle regulated histone transcription. Increased cyclin E2, but not cyclin E1, expression is associated with high expression of replication-dependent histones in breast cancers.ConclusionsThe preferential localisation of cyclin E1 or cyclin E2 to distinct foci indicates that each E-cyclin has unique roles. Cyclin E2 uniquely interacts with NPAT in breast cancer cells, and is associated with higher levels of histones in breast cancer. This could explain the unique correlations of high cyclin E2 expression with poor outcome and genomic instability in breast cancer.

[1]  Peter D. Adams,et al.  HIRA, the Human Homologue of Yeast Hir1p and Hir2p, Is a Novel Cyclin-cdk2 Substrate Whose Expression Blocks S-Phase Progression , 2001, Molecular and Cellular Biology.

[2]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[3]  J. Qin,et al.  Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. , 2000, Genes & development.

[4]  Cristin G. Print,et al.  Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells , 2012, Molecular Cancer Therapeutics.

[5]  J. Aten,et al.  Measurement of co‐localization of objects in dual‐colour confocal images , 1993, Journal of microscopy.

[6]  J. Maller,et al.  A Centrosomal Localization Signal in Cyclin E Required for Cdk2-Independent S Phase Entry , 2004, Science.

[7]  M. Bornens,et al.  Structural and chemical characterization of isolated centrosomes. , 1987, Cell motility and the cytoskeleton.

[8]  G. Mills,et al.  LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients , 2012, PLoS genetics.

[9]  J. Carroll,et al.  Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc , 2009, Molecular and Cellular Biology.

[10]  E. Musgrove,et al.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer , 2010, Cell Division.

[11]  E. Lees,et al.  Cyclin E, a potential prognostic marker for breast cancer. , 1994, Cancer research.

[12]  R. Sutherland,et al.  The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini. , 2008, Cancer research.

[13]  J. Labbé,et al.  Greatwall maintains mitosis through regulation of PP2A , 2009, The EMBO journal.

[14]  R. Sutherland,et al.  Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells , 2013, Cell cycle.

[15]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[16]  G. Stein,et al.  The subnuclear organization of histone gene regulatory proteins and 3′ end processing factors of normal somatic and embryonic stem cells is compromised in selected human cancer cell types , 2009, Journal of cellular physiology.

[17]  Darjus F. Tschaharganeh,et al.  Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. , 2009, Gastroenterology.

[18]  B. Clurman,et al.  Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.

[19]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[20]  K. Helin,et al.  NPAT Expression Is Regulated by E2F and Is Essential for Cell Cycle Progression , 2003, Molecular and Cellular Biology.

[21]  S. Moreno,et al.  Lsm1 promotes genomic stability by controlling histone mRNA decay , 2011, The EMBO journal.

[22]  Bruce Stillman,et al.  Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis , 2000, Molecular and Cellular Biology.

[23]  B. Dynlacht,et al.  Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. , 1998, Genes & development.

[24]  E. Lees,et al.  Cyclin E Associates with Components of the Pre-mRNA Splicing Machinery in Mammalian Cells , 1998, Molecular and Cellular Biology.

[25]  R. Sutherland,et al.  Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1 , 2013, Cell cycle.

[26]  J. Pines,et al.  Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. , 2002, Molecular biology of the cell.